Research output per year
Research output per year
Personal profile
About
Dr. Ramesh V. Nathan is an infectious disease specialist in Thousand Oaks, California and is affiliated with multiple hospitals in the area, including Los Robles Hospital and Medical Center and Simi Valley Hospital. He received his medical degree from George Washington University.
Related documents
Education/Academic qualification
Fellowship, Infectious Disease, Cedars-Sinai Medical Center
2003 → 2005
Residency, Internal Medicine, Cedars-Sinai Medical Center
2000 → 2003
MD, School of Medicine, George Washington University
… → 2000
Research Interests
- Healthcare Associated Infections
Disciplines
- Medicine and Health Sciences
- Infectious Disease
Research output
- 18 Article
-
Using a nurse-initiated bedside tool to decrease inappropriate testing for Clostridioides difficile in hospital settings:
Lenz, A., Davis, G., Asmar, H., Nahapetian, A., Dingilian, J. & Nathan, R. V., May 1 2021, In: Journal of Infection Prevention. 22, 3Research output: Contribution to journal › Article › peer-review
-
1625. Real-World Outpatient Utilization of Ceftolozane/Tazobactam in Physician Office Infusion Centers (OICs)
Van Anglen, L. J., Nathan, R. V., Metzger, B. S., Luu, Q. & Schroeder, C. P., Dec 31 2020, In: Open Forum Infectious Diseases. 7Research output: Contribution to journal › Article › peer-review
-
614. Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections and Bacteremia in Infectious Disease Outpatient Infusion Clinics
Metzger, B. S., Prokesch, R. C., Bernett, J. R., Mandel, R. M., Nathan, R. V., Stock, K., Hardin, T. C., Schroeder, C. P. & Van Anglen, L. J., Dec 31 2020, In: Open Forum Infectious Diseases. 7Research output: Contribution to journal › Article › peer-review
-
787. Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients vs. non-C. difficile Patients in Outpatient Infusion Centers
Garey, K. W., Hengel, R. L., Ritter, T. E., Nathan, R. V., Schroeder, C. P., da Costa, G. L. P., Lancaster, C. K., N, E. & Van Anglen, L. J., Dec 31 2020, In: Open Forum Infectious Diseases. 7Research output: Contribution to journal › Article › peer-review
-
Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study.
Hengel, R. L., Ritter, T. E., Nathan, R. V., Van Anglen, L. J., Schroeder, C. P., Dillon, R. J., Marcella, S. W. & Garey, K. W., Mar 19 2020, In: Open Forum Infectious Diseases. 7, 4Research output: Contribution to journal › Article › peer-review